MedTrace Logo

Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France

NCT03119922 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1750

Last updated 2017-04-19

No results posted yet for this study

Summary

The main objective of this study is to evaluate at the national level (France)

* the early healthcare practices for children with sickle cell disease screened at birth,
* the adequacy of theses practices with the national recommendations,
* their variability over time and according the characteristics of treatment centers.

Will be studied in particular the diffusion of the latest preventive measures (practice of trans-cranial Doppler and pneumococcal conjugate vaccine) and their link with the residual risks of death, stroke and invasive pneumococcal infections. The study includes all patients born in France between 01/01/2006 and 31/12/2010. Events are recorded and analysed only during the first 5 years of life.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • CNAMTS

    collaborator UNKNOWN

  • AFDPHE

    collaborator UNKNOWN

  • National reference center for thalassemia

    collaborator UNKNOWN

  • National laboratories in charge of the SCD new born screening

    collaborator UNKNOWN

  • Reference and competence centers for RBC disorders

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
3 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2016-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03119922 on ClinicalTrials.gov